Mounjaro®
Starting from £179.99/mo
Start journey Learn moreOn Mounjaro, the things you eat, drink and do matter more than most people expect. High-fat meals, alcohol, certain medicines and skipping hydration can all blunt the treatment's effect or make side effects considerably harder to manage. Mounjaro (tirzepatide) is a prescription-only medicine; a GPhC-registered prescriber assesses every patient individually, and your specific avoid-list may differ from someone else's depending on your health history. The guidance below reflects what the NHS and clinical evidence recommend for adults on tirzepatide — use it as a starting point for the conversation with your prescriber, not a substitute for it.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide slows the rate at which the stomach empties, that is part of how it reduces appetite. The side effect of that mechanism is that food lingers longer, and anything that is already hard to digest becomes even harder. Greasy takeaways, deep-fried food, cream sauces and very spicy dishes are the most common triggers for nausea and vomiting on Mounjaro, particularly in the first few weeks or after a dose step-up.
Large portions are a separate but related issue. Because the medicine suppresses hunger, patients sometimes feel full after a few bites and then try to eat more out of habit, the result is reflux, bloating or vomiting. Smaller, more frequent meals generally sit better than two or three large ones. Prioritising protein (chicken, fish, eggs, legumes) and vegetables at each meal helps maintain muscle and keeps you feeling steadier. The NHS tirzepatide patient page notes that dietary choices meaningfully affect how well the medicine is tolerated.
Fizzy drinks and carbonated water can worsen bloating and burping, both listed side effects of tirzepatide. Plain water, taken steadily through the day, is a better default. Dehydration from reduced food and fluid intake is a genuine risk, so sipping consistently (even when you do not feel thirsty) matters throughout treatment. If you want a fuller breakdown of how specific foods interact with Mounjaro, our page covering what to avoid when taking Mounjaro goes through the full picture, including drinks, foods and habits that tend to make side effects worse.
Most clinical guidance stops short of banning alcohol outright, but there are real reasons to be cautious. Alcohol independently affects blood glucose, and if you are also taking Mounjaro for type 2 diabetes management, that interaction is clinically significant. For people using it purely for weight management, the main concerns are more practical: alcohol tends to be high in calories and tends to lower the inhibitions that help people stick to reduced-calorie eating, both of which pull against the medicine's purpose.
There is also a dehydration angle. Tirzepatide can cause nausea, vomiting and diarrhoea, especially early on. Alcohol compounds dehydration. On a bad GI day, adding alcohol can tip someone into a state where they need medical support. The dizziness that some patients report on Mounjaro (listed on the NHS tirzepatide medicines page) can interact with alcohol in the same way. The honest position is that occasional, moderate alcohol is unlikely to cause a crisis for most people, but drinking heavily or regularly on tirzepatide is not advisable, and your prescriber is the right person to talk to about your specific situation.
One thing worth knowing: some patients on GLP-1 medicines notice their desire for alcohol changes, often decreasing. That is reported anecdotally and is the subject of ongoing research, but you should not count on it as a guaranteed effect.
The interaction most consistently highlighted in UK guidance involves oral contraceptives. The MHRA advises that women taking Mounjaro should add a non-oral method of contraception (condoms, for example) for the first four weeks of starting treatment and for four weeks after every dose increase. This is because the slower gastric emptying caused by tirzepatide may reduce how well the pill is absorbed. There is no equivalent warning for semaglutide, so this is tirzepatide-specific. NHS England's guidance on weight management injections covers both the contraception and HRT points clearly.
On HRT: if you are using oral HRT rather than a patch or gel, the same absorption concern applies. NHS England suggests discussing a switch to transdermal HRT with your doctor while on tirzepatide. This is not always necessary, but it is worth raising.
Surgery is another situation requiring proactive disclosure. Your healthcare team and anaesthetist need to know you are on Mounjaro before any procedure, delayed gastric emptying carries anaesthetic risks. Do not assume your GP record will flag it automatically.
On the lifestyle side, long sedentary periods alongside reduced calorie intake can lead to muscle loss that accelerates changes to body composition. Bone density is a related area of interest; if you want to understand what the current evidence says, our page on Mounjaro and bone density covers the research. Strength-based exercise, even light resistance work at home, is widely recommended alongside any GLP-1 treatment, and you can also find practical guidance on how to avoid Mounjaro face as part of looking after your overall body composition during treatment. Think of it less as a gym obligation and more as protecting the body you are changing.
Most side effects on Mounjaro are gastrointestinal, mild and settle within a couple of weeks of each dose step. But some symptoms need prompt attention and it is important to recognise them. Severe stomach pain that spreads to the back (with or without vomiting) can indicate pancreatitis, which the MHRA identified in a Drug Safety Update as an infrequent but serious risk with GLP-1 medicines. Do not wait to see if it passes; get urgent medical assessment.
Signs of dehydration from persistent vomiting or diarrhoea (extreme thirst, very dark urine, confusion, not passing urine) also need urgent care. Symptoms of a serious allergic reaction (facial swelling, difficulty breathing, a spreading rash) require calling 999. Gallbladder symptoms such as severe pain in the upper right abdomen, particularly after eating, should prompt a call to your GP or 111.
Low mood or thoughts of self-harm are listed as possible side effects to watch for; contact your GP or call 111 if these arise. Suspected side effects can be reported directly to the MHRA using the Yellow Card scheme, which helps regulators track safety signals in real-world use. Our prescribers are also available for aftercare seven days a week if you have concerns that fall short of an emergency, get in touch with us at any point during your treatment.
If you are considering treatment or transferring from another provider, our Mounjaro overview sets out how the medicine works and what the full process at nume looks like. For anything related to how treatment is assessed and priced privately, our guide to Mounjaro costs in the UK is a useful read before you start.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.